MicroPort CardioFlow Medtech Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
MicroPort CardioFlow Medtech heeft een totaal eigen vermogen van CN¥2.2B en een totale schuld van CN¥27.0M, wat de schuld-eigenvermogensverhouding op 1.2% brengt. De totale activa en totale passiva bedragen respectievelijk CN¥2.5B en CN¥299.8M.
Belangrijke informatie
1.2%
Verhouding schuld/eigen vermogen
CN¥27.00m
Schuld
| Rente dekkingsratio | n/a |
| Contant | CN¥1.56b |
| Aandelen | CN¥2.20b |
| Totaal verplichtingen | CN¥299.80m |
| Totaal activa | CN¥2.50b |
Recente financiële gezondheidsupdates
MicroPort CardioFlow Medtech (HKG:2160) Is In A Good Position To Deliver On Growth Plans
May 29
We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth
Feb 23Companies Like MicroPort CardioFlow Medtech (HKG:2160) Are In A Position To Invest In Growth
Oct 04We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth
May 23MicroPort CardioFlow Medtech (HKG:2160) Is In A Good Position To Deliver On Growth Plans
Feb 08We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth
Oct 18Recent updates
MicroPort CardioFlow Medtech Corporation (HKG:2160) Stocks Shoot Up 34% But Its P/S Still Looks Reasonable
Sep 27After Leaping 34% MicroPort CardioFlow Medtech Corporation (HKG:2160) Shares Are Not Flying Under The Radar
Sep 27Are Investors Undervaluing MicroPort CardioFlow Medtech Corporation (HKG:2160) By 43%?
Aug 07Some MicroPort CardioFlow Medtech Corporation (HKG:2160) Shareholders Look For Exit As Shares Take 26% Pounding
Jun 19MicroPort CardioFlow Medtech (HKG:2160) Is In A Good Position To Deliver On Growth Plans
May 29MicroPort CardioFlow Medtech Corporation (HKG:2160) Shares May Have Slumped 29% But Getting In Cheap Is Still Unlikely
Apr 05We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth
Feb 23An Intrinsic Calculation For MicroPort CardioFlow Medtech Corporation (HKG:2160) Suggests It's 37% Undervalued
Jan 18Companies Like MicroPort CardioFlow Medtech (HKG:2160) Are In A Position To Invest In Growth
Oct 04Not Many Are Piling Into MicroPort CardioFlow Medtech Corporation (HKG:2160) Stock Yet As It Plummets 27%
May 31We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth
May 23The MicroPort CardioFlow Medtech Corporation (HKG:2160) Analysts Have Been Trimming Their Sales Forecasts
Apr 06MicroPort CardioFlow Medtech (HKG:2160) Is In A Good Position To Deliver On Growth Plans
Feb 08We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth
Oct 18We're Not Very Worried About MicroPort CardioFlow Medtech's (HKG:2160) Cash Burn Rate
Jun 30Analysts Just Made A Major Revision To Their MicroPort CardioFlow Medtech Corporation (HKG:2160) Revenue Forecasts
Apr 04MicroPort CardioFlow Medtech Corporation (HKG:2160) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Apr 03An Intrinsic Calculation For MicroPort CardioFlow Medtech Corporation (HKG:2160) Suggests It's 49% Undervalued
Jan 21Are Investors Undervaluing MicroPort CardioFlow Medtech Corporation (HKG:2160) By 24%?
Sep 05We're Not Worried About MicroPort CardioFlow Medtech's (HKG:2160) Cash Burn
Jun 07Market Sentiment Around Loss-Making MicroPort CardioFlow Medtech Corporation (HKG:2160)
May 03Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( CN¥1.9B ) 2160 } overtreffen de korte termijn passiva ( CN¥249.1M ).
Langlopende schulden: De kortetermijnactiva 2160 ( CN¥1.9B ) overtreffen de langetermijnschulden ( CN¥50.7M ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 2160 heeft meer geld in kas dan de totale schuld.
Schuld verminderen: De schuld/eigen vermogen-ratio van 2160 is de afgelopen 5 jaar gedaald van 24.3% naar 1.2%.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: 2160 heeft op basis van de huidige vrije kasstroom voldoende cash runway voor meer dan 3 jaar.
Voorspelling contante baan: Er zijn onvoldoende gegevens om te bepalen of 2160 voldoende cash runway heeft als de vrije kasstroom blijft groeien of krimpen op basis van historische percentages.